464 related articles for article (PubMed ID: 16779732)
1. Administration of live varicella vaccine to HIV-infected children with current or past significant depression of CD4(+) T cells.
Levin MJ; Gershon AA; Weinberg A; Song LY; Fentin T; Nowak B;
J Infect Dis; 2006 Jul; 194(2):247-55. PubMed ID: 16779732
[TBL] [Abstract][Full Text] [Related]
2. Immunization of HIV-infected children with varicella vaccine.
Levin MJ; Gershon AA; Weinberg A; Blanchard S; Nowak B; Palumbo P; Chan CY;
J Pediatr; 2001 Aug; 139(2):305-10. PubMed ID: 11487761
[TBL] [Abstract][Full Text] [Related]
3. Safety and immunogenicity of live varicella virus vaccine in children with human immunodeficiency virus type 1.
Armenian SH; Han JY; Dunaway TM; Church JA
Pediatr Infect Dis J; 2006 Apr; 25(4):368-70. PubMed ID: 16567993
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity of a two-dose regime of varicella vaccine in children with cancers.
Leung TF; Li CK; Hung EC; Chan PK; Mo CW; Wong RP; Chik KW
Eur J Haematol; 2004 May; 72(5):353-7. PubMed ID: 15059071
[TBL] [Abstract][Full Text] [Related]
5. Varicella vaccination in HIV-1-infected children after immune reconstitution.
Bekker V; Westerlaken GH; Scherpbier H; Alders S; Zaaijer H; van Baarle D; Kuijpers T
AIDS; 2006 Nov; 20(18):2321-9. PubMed ID: 17117018
[TBL] [Abstract][Full Text] [Related]
6. Antibody responses to hepatitis A virus vaccine in HIV-infected children with evidence of immunologic reconstitution while receiving highly active antiretroviral therapy.
Weinberg A; Gona P; Nachman SA; Defechereux P; Yogev R; Hughes W; Wara D; Spector SA; Read J; Elgie C; Cooper M; Dankner W;
J Infect Dis; 2006 Jan; 193(2):302-11. PubMed ID: 16362896
[TBL] [Abstract][Full Text] [Related]
7. Varicella-zoster virus infection in Romanian children infected with the human immunodeficiency virus.
Leibovitz E; Cooper D; Giurgiutiu D; Coman G; Straus I; Orlow SJ; Lawrence R
Pediatrics; 1993 Dec; 92(6):838-42. PubMed ID: 7901834
[TBL] [Abstract][Full Text] [Related]
8. Prevention and treatment of VZV infections in patients with HIV.
Gershon AA
Herpes; 2001 Jul; 8(2):32-6. PubMed ID: 11867015
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of Oka/Merck varicella vaccine in children vaccinated at 12-14 months of age versus 15-23 months of age.
Silber JL; Chan IS; Wang WW; Matthews H; Kuter BJ
Pediatr Infect Dis J; 2007 Jul; 26(7):572-6. PubMed ID: 17596796
[TBL] [Abstract][Full Text] [Related]
10. Loss of varicella zoster virus antibodies despite detectable cell mediated immunity after vaccination.
Ludwig B; Kraus FB; Allwinn R; Keim S; Doerr HW; Buxbaum S
Infection; 2006 Aug; 34(4):222-6. PubMed ID: 16896582
[TBL] [Abstract][Full Text] [Related]
11. The immunogenicity and safety of live attenuated varicella-zoster virus vaccine in human immunodeficiency virus-infected children.
Taweesith W; Puthanakit T; Kowitdamrong E; Bunupuradah T; Wongngam W; Phasomsap C; Apornpong T; Bouko C; Pancharoen C
Pediatr Infect Dis J; 2011 Apr; 30(4):320-4. PubMed ID: 20975615
[TBL] [Abstract][Full Text] [Related]
12. Persistent humoral immune defect in highly active antiretroviral therapy-treated children with HIV-1 infection: loss of specific antibodies against attenuated vaccine strains and natural viral infection.
Bekker V; Scherpbier H; Pajkrt D; Jurriaans S; Zaaijer H; Kuijpers TW
Pediatrics; 2006 Aug; 118(2):e315-22. PubMed ID: 16847077
[TBL] [Abstract][Full Text] [Related]
13. Prevention of varicella: recommendations for use of varicella vaccines in children, including a recommendation for a routine 2-dose varicella immunization schedule.
American Academy of Pediatrics Committee on Infectious Diseases
Pediatrics; 2007 Jul; 120(1):221-31. PubMed ID: 17606582
[TBL] [Abstract][Full Text] [Related]
14. Ten year follow-up of healthy children who received one or two injections of varicella vaccine.
Kuter B; Matthews H; Shinefield H; Black S; Dennehy P; Watson B; Reisinger K; Kim LL; Lupinacci L; Hartzel J; Chan I;
Pediatr Infect Dis J; 2004 Feb; 23(2):132-7. PubMed ID: 14872179
[TBL] [Abstract][Full Text] [Related]
15. Varicella-Zoster virus-specific cell-mediated immunity in HIV-infected children receiving highly active antiretroviral therapy.
Weinberg A; Wiznia AA; LaFleur BJ; Shah S; Levin MJ
J Infect Dis; 2004 Jul; 190(2):267-70. PubMed ID: 15216460
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity, safety, and predictors of response after a pneumococcal conjugate and pneumococcal polysaccharide vaccine series in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy.
Abzug MJ; Pelton SI; Song LY; Fenton T; Levin MJ; Nachman SA; Borkowsky W; Rosenblatt HM; Marcinak JF; Dieudonne A; Abrams EJ; Pathak I;
Pediatr Infect Dis J; 2006 Oct; 25(10):920-9. PubMed ID: 17006288
[TBL] [Abstract][Full Text] [Related]
17. One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?
Lopez AS; Guris D; Zimmerman L; Gladden L; Moore T; Haselow DT; Loparev VN; Schmid DS; Jumaan AO; Snow SL
Pediatrics; 2006 Jun; 117(6):e1070-7. PubMed ID: 16740809
[TBL] [Abstract][Full Text] [Related]
18. The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis.
Nachman S; Gona P; Dankner W; Weinberg A; Yogev R; Gershon A; Rathore M; Read JS; Huang S; Elgie C; Hudgens K; Hughes W
Pediatrics; 2005 Apr; 115(4):e488-94. PubMed ID: 15772172
[TBL] [Abstract][Full Text] [Related]
19. Antibody response after varicella vaccination in children treated with budesonide inhalation suspension or non-steroidal conventional asthma therapy.
Murphy K; Ververeli K; Harvey BM; Duke AL; Chapas-Crilly J; Uryniak T; Lyzell E; Mezzanotte W
Int J Clin Pract; 2006 Dec; 60(12):1548-57. PubMed ID: 17109664
[TBL] [Abstract][Full Text] [Related]
20. Humoral and cell-mediated immune responses in children and adults after 1 and 2 doses of varicella vaccine.
Watson B
J Infect Dis; 2008 Mar; 197 Suppl 2():S143-6. PubMed ID: 18419388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
